Skip to main content
. 2010 Sep;5(9):1588–1594. doi: 10.2215/CJN.00210110

Figure 2.

Figure 2.

Plasma concentration-time curves (mean ± SEM) of (A) HCY and (B) CYS observed after oral administration of sustained-release NAC 600 mg (circles) or 1200 mg (triangles) to ESRD subjects and NAC 600 mg to healthy control subjects (squares) for 14 d. Baseline concentrations observed on day 1 are also depicted.